max dose of retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide: The New Triple-Agonist Weight

Sermorelins documented human uses are diagnostic testing and pediatric growth-hormone deficiency

While highly effective, one of the common side effects reported by patients using GLP-1 medications is constipation

Despite GLP-1 concentration being higher in the fundus than the antrum, its release ex vivo upon IBMX stimulation increases to the same extent in both the fundus and antrum, suggesting a significant contribution to both portal and gastric GLP-1 (Ribeiro-Parenti et al., 2021)

Evolution of Professional Guidance The 2023 ASA consensus-based guidance The 2023 ASA consensus guidance was issued during a period of rapidly rising GLP-1 use and increasing concern from case reports

Table I summarizes recent in vitro studies examining the role of lactate in ferroptosis regulation

Hyperpigmentation such as sun spots, age spots, melasma, and post-inflammatory marks from acne or injuries